Veracyte Raises FY2026 Sales Guidance from $570.000M-$582.000M to $582.000M-$592.000M vs $576.521M Est

Benzinga Newsdesk www.benzinga.com Positive 94.3%

Neg 0% Neu 0% Pos 94.3%

Veracyte (NASDAQ:VCYT) raises FY2026 sales outlook from $570.000 million-$582.000 million to $582.000 million-$592.000 million vs $576.521 million estimate.